CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders.
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reach the brain.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 14, 2020 | Series C | €10.50M | 1 | European Innovation Council | — | Detail |
Sep 14, 2020 | Grant | €2M | 1 | European Innovation Council | — | Detail |
Dec 12, 2018 | Series B | €9M | 4 | — | — | Detail |
Oct 12, 2016 | Grant | €5.70M | — | — | — | Detail |
Apr 13, 2015 | Series A | €2.10M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Innovation Council | Yes | Series C |
Groupe Arnault | — | Series B |
Panakes Partners | — | Series B |
Sham Innovation Santé | — | Series B |
Supernova Invest | — | Series B |
AGORANOV | — | Seed |